This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …

Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …

In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccines were licensed and recommended for use in adults and adolescents in the United …

Despite sustained high coverage for childhood pertussis vaccination, pertussis remains
poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths …

Importance Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and
acellular pertussis (Tdap) vaccine could prevent infant pertussis. Objective To evaluate the …

Background Infants aged< 1 year are at highest risk for pertussis-related morbidity and
mortality. In 2012, Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) …

Pertussis is a highly contagious, vaccine-preventable bacterial illness characterized by
paroxysmal cough, posttussive vomiting, and inspiratory whoop. Pertussis also can occur as …

Background Immunization of pregnant women with tetanus-diphtheria-acellular pertussis
vaccine (Tdap) provides protection against pertussis to the newborn infant. Methods In a …

Background. Pertussis is among the most poorly controlled bacterial vaccine-preventable
diseases in the United States. In 2006, a tetanus, reduced-dose diphtheria, and acellular …